153 related articles for article (PubMed ID: 1862257)
21. Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis.
Cazzola M; Calzetta L; Page C; Rogliani P; Matera MG
Pulm Pharmacol Ther; 2018 Feb; 48():185-194. PubMed ID: 29233650
[TBL] [Abstract][Full Text] [Related]
22. [Double blind study of the mucoregulating action of sodium thiophene carboxylate (author's transl)].
Cheminat JC; Aiache JM
Sem Hop; 1981 Feb 8-15; 57(5-6):307-10. PubMed ID: 6259755
[TBL] [Abstract][Full Text] [Related]
23. Changes in blood ROS, e-NO, and some pro-inflammatory mediators in bronchial secretions following erdosteine or placebo: a controlled study in current smokers with mild COPD.
Dal Negro RW; Visconti M; Micheletto C; Tognella S
Pulm Pharmacol Ther; 2008; 21(2):304-8. PubMed ID: 17889580
[TBL] [Abstract][Full Text] [Related]
24. Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats.
Fadillioğlu E; Erdoğan H; Söğüt S; Kuku I
J Appl Toxicol; 2003; 23(1):71-4. PubMed ID: 12518339
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine.
Rogliani P; Matera MG; Page C; Puxeddu E; Cazzola M; Calzetta L
Respir Res; 2019 May; 20(1):104. PubMed ID: 31133026
[TBL] [Abstract][Full Text] [Related]
26. Rheological profile of nesosteine: a new mucoactive agent.
Braga PC; Beghi G; Castelli C; Grasselli G; Ornaghi A; Rampoldi C; Zheng Y; Allegra L
Int J Clin Pharmacol Res; 1989; 9(1):77-83. PubMed ID: 2707929
[TBL] [Abstract][Full Text] [Related]
27. Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent.
Cazzola M; Page C; Rogliani P; Calzetta L; Matera MG
Drugs; 2020 Nov; 80(17):1799-1809. PubMed ID: 33025535
[TBL] [Abstract][Full Text] [Related]
28. Protective role of erdosteine pretreatment on oleic acid-induced acute lung injury.
Erdem A; Gedikli E; Yersal N; Karaismailoglu S; Muftuoglu S; Fadillioglu E; Tuncer M
J Surg Res; 2017 Jun; 213():234-242. PubMed ID: 28601320
[TBL] [Abstract][Full Text] [Related]
29. Effect of bamiphylline on tracheobronchial mucus clearance in subjects with smokers' simple chronic bronchitis.
Todisco T; Baglioni S; Amir E; Palumbo R
Respiration; 1995; 62(1):16-20. PubMed ID: 7716349
[TBL] [Abstract][Full Text] [Related]
30. Protection of erdosteine on smoke-induced peripheral neutrophil dysfunction both in healthy and in bronchitic smokers.
Ciaccia A; Papi A; Tschirky B; Fregnan B
Fundam Clin Pharmacol; 1992; 6(8-9):375-82. PubMed ID: 1292969
[TBL] [Abstract][Full Text] [Related]
31. The effect of a new expectorant drug on mucus transport in chronic bronchitis.
Santolicandro A; Baldi S; Giuntini C
J Aerosol Med; 1995; 8(1):33-42. PubMed ID: 10150489
[TBL] [Abstract][Full Text] [Related]
32. Relationship between bronchial reversibility and tracheobronchial clearance in patients with chronic bronchitis.
Moretti M; Lopez-Vidriero MT; Pavia D; Clarke SW
Thorax; 1997 Feb; 52(2):176-80. PubMed ID: 9059481
[TBL] [Abstract][Full Text] [Related]
33. The protective effect of erdosteine against cyclosporine A-induced cardiotoxicity in rats.
Selcoki Y; Uz E; Bayrak R; Sahin S; Kaya A; Uz B; Karanfil A; Ozkara A; Akcay A
Toxicology; 2007 Sep; 239(1-2):53-9. PubMed ID: 17689165
[TBL] [Abstract][Full Text] [Related]
34. Erdosteine treatment attenuates oxidative stress and fibrosis in experimental biliary obstruction.
Sener G; Sehirli AO; Toklu HZ; Yuksel M; Ercan F; Gedik N
Pediatr Surg Int; 2007 Mar; 23(3):233-41. PubMed ID: 17216233
[TBL] [Abstract][Full Text] [Related]
35. Acute and Chronic Effects of Oral Erdosteine on Ciliary Beat Frequency, Cough Sensitivity and Airway Reactivity.
Pappová L; Kazimierová I; Jošková M; Šutovská M; Fraňová S
Adv Exp Med Biol; 2018; 1023():1-10. PubMed ID: 28730380
[TBL] [Abstract][Full Text] [Related]
36. [ Erdosteine (Mucodox), oral administration].
J Pharm Belg; 2011 Jun; (2):55-6. PubMed ID: 21823444
[No Abstract] [Full Text] [Related]
37. The effect of long-term treatment with erdosteine on chronic obstructive pulmonary disease: the EQUALIFE Study.
Moretti M; Bottrighi P; Dallari R; Da Porto R; Dolcetti A; Grandi P; Garuti G; Guffanti E; Roversi P; De Gugliemo M; Potena A;
Drugs Exp Clin Res; 2004; 30(4):143-52. PubMed ID: 15553660
[TBL] [Abstract][Full Text] [Related]
38. Effect of aerosolized uridine 5'-triphosphate on mucociliary clearance in mild chronic bronchitis.
Bennett WD; Zeman KL; Foy C; Shaffer CL; Johnson FL; Regnis JA; Sannuti A; Johnson J
Am J Respir Crit Care Med; 2001 Jul; 164(2):302-6. PubMed ID: 11463605
[TBL] [Abstract][Full Text] [Related]
39. Use of mucolytics in COPD: A Delphi consensus study.
Papi A; Avdeev S; Calverley PMA; Cordeiro CR; Jesenak M; Koblížek V; Petkova D; Rogliani P; Tarraf H; Tzanakis N; Ulmeanu R; Uzaslan E; Adir Y
Respir Med; 2020 Dec; 175():106190. PubMed ID: 33217537
[TBL] [Abstract][Full Text] [Related]
40. Erdosteine ameliorates lung injury induced by transient aortic occlusion in rats.
Kurtoglu T; Sacar M; Inan BK; Duver MH; Guler A; Ucak A; Us MH; Yilmaz AT
Cardiovasc J Afr; 2007; 18(6):367-70. PubMed ID: 18092111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]